Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Bowman

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|September 8, 2016
Goldilocks' Determination of What New In Vivo Data are "Just Right" for Different Common Drug Development Scenarios, Part 1Christopher J Bowman, Robert E Chapin
ACG Case Reports Journal|June 14, 2021
A Masked Diagnosis: Sigmoid EndometriosisLakshmipriya Subbaraj, Christopher J Bowman, Aparajita Singh
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|August 31, 2010
Maternal-placental insulin-like growth factor (IGF) signaling and its importance to normal embryo-fetal developmentChristopher J Bowman, Randal D Streck, Robert E Chapin
Current Drug Metabolism|August 20, 2013
Neonatal Fc receptor and its role in the absorption, distribution, metabolism and excretion of immunoglobulin G-based biotherapeuticsCraig Giragossian, Tracey Clark, Nicole Piché-Nicholas, et al.
ASM Case Reports|November 17, 2025
Two cases of Legionnaires' disease due to <i>Legionella cardiaca</i>Xiang Y Han, Christopher J Bowman, Micah M Bhatti, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|August 30, 2012
Object discrimination reversal as a method to assess cognitive impairment in nonhuman primate enhanced pre- and postnatal developmental (ePPND) studies: statistical power analysisGregg D Cappon, Christopher J Bowman, Mark E Hurtt, et al.
Birth Defects Research|May 5, 2025
Perspectives on Implementing Virtual Control Groups in Developmental and Reproductive Toxicity StudiesL David Wise, Alan M Hoberman, Christopher J Bowman, et al.
Molecular and Cellular Endocrinology|October 19, 2002
Estradiol-induced gene expression in largemouth bass (Micropterus salmoides)Christopher J Bowman, Kevin J Kroll, Timothy G Gross, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2026
Foxp1 controls Fezf2-dependent gene expression, mimetic mTEC diversity, and thymic central toleranceJun Hyung Sin, Christopher J Bowman, Juliana Sucharov, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|June 12, 2010
Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeysChristopher J Bowman, Gary Chmielewski, Satoru Oneda, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|September 8, 2016
Goldilocks' Determination of What New In Vivo Data are "Just Right" for Different Common Drug Development Scenarios, Part 1Christopher J Bowman, Robert E Chapin
ACG Case Reports Journal|June 14, 2021
A Masked Diagnosis: Sigmoid EndometriosisLakshmipriya Subbaraj, Christopher J Bowman, Aparajita Singh
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|August 31, 2010
Maternal-placental insulin-like growth factor (IGF) signaling and its importance to normal embryo-fetal developmentChristopher J Bowman, Randal D Streck, Robert E Chapin
Current Drug Metabolism|August 20, 2013
Neonatal Fc receptor and its role in the absorption, distribution, metabolism and excretion of immunoglobulin G-based biotherapeuticsCraig Giragossian, Tracey Clark, Nicole Piché-Nicholas, et al.
ASM Case Reports|November 17, 2025
Two cases of Legionnaires' disease due to <i>Legionella cardiaca</i>Xiang Y Han, Christopher J Bowman, Micah M Bhatti, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|August 30, 2012
Object discrimination reversal as a method to assess cognitive impairment in nonhuman primate enhanced pre- and postnatal developmental (ePPND) studies: statistical power analysisGregg D Cappon, Christopher J Bowman, Mark E Hurtt, et al.
Birth Defects Research|May 5, 2025
Perspectives on Implementing Virtual Control Groups in Developmental and Reproductive Toxicity StudiesL David Wise, Alan M Hoberman, Christopher J Bowman, et al.
Molecular and Cellular Endocrinology|October 19, 2002
Estradiol-induced gene expression in largemouth bass (Micropterus salmoides)Christopher J Bowman, Kevin J Kroll, Timothy G Gross, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2026
Foxp1 controls Fezf2-dependent gene expression, mimetic mTEC diversity, and thymic central toleranceJun Hyung Sin, Christopher J Bowman, Juliana Sucharov, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|June 12, 2010
Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeysChristopher J Bowman, Gary Chmielewski, Satoru Oneda, et al.
Pageof 7